Foremost Companies in the Long-Read Sequencing Market: Oxford Nanopore Technologies plc. (UK) and PacBio (US)
The long-read sequencing market is expected to reach USD 3,129 million in 2029 from USD 758 million in 2024, at a CAGR of 32.8% during the forecast period. The main forces behind the expansion of this market are the rising frequency of complex genetic disorders, expanding applications of long-read sequencing, and the technological development in genome sequencing aiding in the adoption of third-generation sequencing. The global long-read sequencing market is consolidated with top players such as PacBio (US), Oxford Nanopore Technologies plc. (UK), Illumina, Inc. (US). The market players have adopted various strategies such as new product launches, collaborations, and geographical expansions to strengthen their position in the global long-read sequencing market.
Oxford Nanopore Technologies plc. (UK)
Oxford Nanopore Technologies is a biotechnology firm that develops proprietary technological platforms. Through its Life Science Research Tools segment, the firm competently operates in the long-read sequencing market. The company has a strong geographic presence across 100 countries. The company utilizes strategic pricing strategies for its products like flow cells and other consumables to avail this to clinical, academic, and research populations across the world. The company implements organic and inorganic growth strategies to support its business growth. For instance, in June 2023, they announced a research collaboration agreement with the National German Initiative to advance the research of rare diseases with nanopore-based genome sequencing.
To know about the assumptions considered for the study download the pdf brochure
PacBio (US)
Pacific Biosciences is a life science technology company that designs, develops, and manufactures sequencing systems based on HiFi long-read sequencing and single-molecule real-time (SMRT) sequencing technology, which enables single-molecule real-time detection of biological processes. The company caters to pharmaceutical and biotechnology companies, colleges & universities, research institutes, and government bodies (including government testing & diagnostic centers) through its sales and distribution offices network. The company continuously innovates its Sequel systems since they provide great accuracy and high-throughput capacity. For many different genomic and transcriptomic uses, the newest Sequel Il and Sequel Ile systems offer scalable solutions. For instance, in February 2024, PacBio launched two new high-throughput library preparation kits and workflows optimized for its Revio sequencing system.
Illumina, Inc. (US)
Illumina is the leading provider of genome sequencing solutions to assist in the investigation of genetic variants and biological functions. To streamline genetic analysis, the company's offering consists of consumables, integrated systems, and analytical equipment. Through its equipment and consumables division, the company provides several long-read sequencing products. The company also provides long-read sequencing services under its Service and Other Revenue division. The company’s stable investments in research and development helped the company to refine its portfolio along with the innovation to improve its accuracy and bring new uses. For instance, Illumina debuted its first product based on its original Illumina Complete Long Read technology in March 2023. Illumina Complete Long Read Prep, Human — is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems based on high performance, long read, human whole-genome sequencing.
Related Reports:
Long-Read Sequencing Market by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
